SHERRI HERNANDEZ: Open Payments
NPI 1023370954 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 25 payments from 11 companies in 2025. Trend: 2023 $368 · 2024 $579 · 2025 $426
Food & beverage: $405Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Amgen Inc. | 2 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: LEQVIO, Kerendia, REPATHA, FUROSCIX, REXULTI, VOQUEZNA, EVKEEZA, LifeVest.
Industry payments across IN — which companies pay providers there.
